Fibroblast growth factor receptor 2 with Apert mutation (S252W) increase osteoblast differentiation and mineralization.

被引：0
|
作者：
Tanimoto, Y [1 ]
Yokozeki, M [1 ]
Hiura, K [1 ]
Moriyama, K [1 ]
机构：
[1] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 770, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F197
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [1] Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in apert craniosynostosis
    Lemonnier, J
    Hay, E
    Delannoy, P
    Lomri, A
    Modrowski, D
    Caverzasio, J
    Marie, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (05) : 832 - 845
  • [2] S252W mutation in Indian vatients of Apert syndrome
    Girisha, K. M.
    Phadke, Shubha R.
    Khan, Faisal
    Agrawal, Suraksha
    INDIAN PEDIATRICS, 2006, 43 (08) : 733 - 735
  • [3] Detection of the S252W mutation in fibroblast growth factor receptor 2 (FGFR2) in fetal DNA from maternal plasma in a pregnancy affected by Apert syndrome
    Au, Patrick K. C.
    Kwok, Yvonne K. Y.
    Leung, K. Y.
    Tang, Linda Y. F.
    Tang, Mary H. Y.
    Lau, Elizabeth T.
    PRENATAL DIAGNOSIS, 2011, 31 (02) : 218 - 220
  • [4] Acceleration of osteoblastic cell differentiation and mineralization by fibroblast growth factor receptor (FGFR) 2 with apert mutation
    Taninoto, Y
    Yokozeki, M
    Hiura, K
    Matsumoto, K
    Nakanishi, H
    Moriyama, K
    BONE, 2003, 32 (05) : S141 - S141
  • [5] A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome
    Tanimoto, Y
    Yokozeki, M
    Hiura, K
    Matsumoto, K
    Nakanishi, H
    Matsumoto, T
    Marie, PJ
    Moriyama, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) : 45926 - 45934
  • [6] Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly
    Passos-Bueno, MR
    Richieri-Costa, A
    Sertié, AL
    Kneppers, A
    JOURNAL OF MEDICAL GENETICS, 1998, 35 (08) : 677 - 679
  • [7] The Apert S252W mutation in fibroblast growth factor receptor-2 increases apoptosis through PKC, IL-1 and downstream activation of caspases-8 and-3 in human calvaria osteoblasts.
    Lemonnier, J
    Haÿ, E
    Delannoy, P
    Lomri, A
    Fromigué, O
    Marie, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S212 - S212
  • [8] Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans
    McDowell, LM
    Frazier, BA
    Studelska, DR
    Giljum, K
    Chen, JH
    Liu, J
    Yu, K
    Ornitz, DM
    Zhang, LJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 6924 - 6930
  • [9] Mutation of the fibroblast growth factor receptor 2 gene in Japanese patients with Apert syndrome
    Matsumoto, K
    Urano, Y
    Kubo, Y
    Nakanishi, H
    Arase, S
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 101 (02) : 307 - 311
  • [10] Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+/S252W mouse
    Wang, YL
    Xiao, R
    Yang, F
    Karim, BO
    Iacovelli, AJ
    Cai, JL
    Lerner, CP
    Richtsmeier, JT
    Leszl, JM
    Hill, CA
    Yu, K
    Ornitz, DM
    Elisseeff, J
    Huso, DL
    Jabs, EW
    DEVELOPMENT, 2005, 132 (15): : 3537 - 3548
12345